| Schedule of main differences between IFRS and US GAAP |
| For the three months ended |
|
May 31,
2019 |
|
| |
|
|
|
| Net loss and comprehensive loss in accordance with IFRS |
|
$ |
4,792,890 |
|
| |
|
|
|
|
| Share-based compensation |
|
|
(248,912 |
) |
| Debt issue costs |
|
|
(43,799 |
) |
| Net loss and comprehensive loss in accordance with US GAAP |
|
$ |
4,500,179 |
|
| For the nine months ended |
|
May 31,
2019 |
|
| |
|
|
|
| Net loss and comprehensive loss in accordance with IFRS |
|
$ |
13,747,997 |
|
| |
|
|
|
|
| Share-based compensation |
|
|
(746,736 |
) |
| Debt issue costs |
|
|
51,894 |
|
| Net loss and comprehensive loss in accordance with US GAAP |
|
$ |
13,053,155 |
|
|
| Schedule of shareholders' equity |
| |
|
May 31,
2019 |
|
| |
|
|
|
| Total shareholders’ equity in accordance with IFRS |
|
$ |
46,193,400 |
|
| |
|
|
|
|
| Components of share capital in accordance with IFRS |
|
|
|
|
| Share capital |
|
|
100,109,913 |
|
| Shares to be issued |
|
|
1,068,000 |
|
| Share option reserve |
|
|
14,485,974 |
|
| Share warrant reserve |
|
|
6,246,032 |
|
| |
|
|
121,909,919 |
|
| Adjustment for: |
|
|
|
|
| Share-based compensation |
|
|
(217,862 |
) |
| Total share capital in accordance with US GAAP |
|
|
121,692,057 |
|
| |
|
|
|
|
| Accumulated deficit in accordance with IFRS |
|
|
(75,716,519 |
) |
| Adjustment for: |
|
|
|
|
| Share-based compensation |
|
|
217,862 |
|
| Debt issue costs |
|
|
(51,894 |
) |
| Accumulated deficit in accordance with US GAAP |
|
|
(75,550,551 |
) |
| |
|
|
|
|
| Shareholders equity in accordance with US GAAP |
|
$ |
46,141,506 |
|
|